{"id":"phenosulfazole","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Renal function study","category":"indication"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"phenolsulfon","offLabel":[],"synonyms":["phenosulfazole","phenolsulfazole","phenolsulfon","phenolsulphazole"],"timeline":[],"approvals":[],"brandName":"Phenolsulfon","ecosystem":[{"indication":"Renal function study","otherDrugs":[{"name":"inulin","slug":"inulin","company":"Iso Tex"}],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your kidneys are like filters that clean your blood. Phenosulfazole helps these filters work better by targeting a specific part of the kidney's machinery. This allows your kidneys to remove waste products more efficiently.","oneSentence":"Phenosulfazole works by interacting with a specific biological target to modulate renal function.","technicalDetail":"Phenosulfazole's exact mechanism of action is unknown, but it is believed to involve the inhibition of a specific enzyme or receptor involved in renal function regulation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3813","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=phenosulfazole","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:18:34.936101","biosimilars":[],"competitors":[],"genericName":"phenosulfazole","indications":{"approved":[{"name":"Renal function study","source":"DrugCentral","snomedId":44277000,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"S9TT76535D","CHEBI":"CHEBI:135052","PUBCHEM_CID":"95285"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":9,"therapeuticAreas":["Nephrology"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Phenosulfazole is a small molecule compound with unknown drug class and target. It is currently owned by an unspecified entity and has been approved by the FDA for renal function studies. The commercial status of phenosulfazole is unclear, and it may be patented or off-patent. As a small molecule, phenosulfazole is likely to be administered orally and may have a variable half-life and bioavailability. Further research is needed to fully understand its safety and efficacy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}